<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27707729</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>08</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-2060</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>76</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of the rheumatic diseases</Title>
          <ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS).</ArticleTitle>
        <Pagination>
          <StartPage>942</StartPage>
          <EndPage>947</EndPage>
          <MedlinePgn>942-947</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2016-209686</ELocationID>
        <Abstract>
          <AbstractText>Cryopyrin-associated periodic syndrome (CAPS) is a rare, heterogeneous disease entity associated with <i>NLRP3</i> gene mutations and increased interleukin-1 (IL-1) secretion. Early diagnosis and rapid initiation of IL-1 inhibition prevent organ damage. The aim of the study was to develop and validate diagnostic criteria for CAPS. An innovative process was followed including interdisciplinary team building, item generation: review of CAPS registries, systematic literature review, expert surveys, consensus conferences for item refinement, item reduction and weighting using 1000Minds decision software. Resulting CAPS criteria were tested in large cohorts of CAPS cases and controls using correspondence analysis. Diagnostic models were explored using sensitivity analyses. The international team included 16 experts. Systematic literature and registry review identified 33 CAPS-typical items; the consensus conferences reduced these to 14. 1000Minds exercises ranked variables based on importance for the diagnosis. Correspondence analysis determined variables consistently associated with the diagnosis of CAPS using 284 cases and 837 controls. Seven variables were significantly associated with CAPS (p&lt;0.001). The best diagnosis model included: Raised inflammatory markers (C-reactive protein/serum amyloid A) plus ≥two of six CAPS-typical symptoms: urticaria-like rash, cold-triggered episodes, sensorineural hearing loss, musculoskeletal symptoms, chronic aseptic meningitis and skeletal abnormalities. Sensitivity was 81%, specificity 94%. It performed well for all CAPS subtypes and regardless of <i>NLRP3</i> mutation. The novel approach integrated traditional methods of evidence synthesis with expert consensus, web-based decision tools and innovative statistical methods and may serve as model for other rare diseases. These criteria will enable a rapid diagnosis for children and adults with CAPS.</AbstractText>
          <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kuemmerle-Deschner</LastName>
            <ForeName>Jasmin B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pediatric Rheumatology, Department of Pediatrics, University Hospital Tuebingen, Tuebingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ozen</LastName>
            <ForeName>Seza</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tyrrell</LastName>
            <ForeName>Pascal N</ForeName>
            <Initials>PN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kone-Paut</LastName>
            <ForeName>Isabelle</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatric Rheumatology, Reference Centre for Autoinflammatory Disorders CEREMAI, Bicêtre Hospital, University of Paris SUD, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goldbach-Mansky</LastName>
            <ForeName>Raphaela</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Autoinflammatory Disease Section, NIAMS/NIH, Bethesda, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lachmann</LastName>
            <ForeName>Helen</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>National Amyloidosis Centre, University College London Medical School, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blank</LastName>
            <ForeName>Norbert</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Haematologie, Onkologie und Rheumatologie, Universitaetsklinikum Heidelberg, Heidelberg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoffman</LastName>
            <ForeName>Hal M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>University of California at San Diego, San Diego, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weissbarth-Riedel</LastName>
            <ForeName>Elisabeth</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Kinderrheumatologische Ambulanz, Universitaetsklinikum Eppendorf, Hamburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hugle</LastName>
            <ForeName>Boris</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>German Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kallinich</LastName>
            <ForeName>Tilmann</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Charité, University Medicine Berlin, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gattorno</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>UO Pediatria 2, G. Gaslini Institute, Genoa, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gul</LastName>
            <ForeName>Ahmet</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Istanbul University, Istanbul, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ter Haar</LastName>
            <ForeName>Nienke</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oswald</LastName>
            <ForeName>Marlen</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pediatric Rheumatology, Department of Pediatrics, University Hospital Tuebingen, Tuebingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dedeoglu</LastName>
            <ForeName>Fatma</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Boston Children's Hospital, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cantarini</LastName>
            <ForeName>Luca</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Unit, Policlinico Le Scotte, University of Sienna, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Benseler</LastName>
            <ForeName>Susanne M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology, Department of Paediatrics, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 AI052430</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016446">Consensus Development Conference</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
          <PublicationType UI="D023361">Validation Study</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>10</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ann Rheum Dis</MedlineTA>
        <NlmUniqueID>0372355</NlmUniqueID>
        <ISSNLinking>0003-4967</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000685">Serum Amyloid A Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9007-41-4</RegistryNumber>
          <NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C569627">Cold Hypersensitivity</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Ann Rheum Dis. 2016 Apr;76(4):e7</RefSource>
          <PMID Version="1">27799158</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Ann Rheum Dis. 2017 May;76(5):e9</RefSource>
          <PMID Version="1">27852576</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Ann Rheum Dis. 2017 May;76(5):e10</RefSource>
          <PMID Version="1">27899375</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Nat Rev Rheumatol. 2017 Jan;13(1):7-8</RefSource>
          <PMID Version="1">27928157</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Ann Rheum Dis. 2016 Apr;76(4):e8</RefSource>
          <PMID Version="1">27986656</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001842" MajorTopicYN="N">Bone and Bones</DescriptorName>
          <QualifierName UI="Q000002" MajorTopicYN="N">abnormalities</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056587" MajorTopicYN="N">Cryopyrin-Associated Periodic Syndromes</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006319" MajorTopicYN="N">Hearing Loss, Sensorineural</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008582" MajorTopicYN="N">Meningitis, Aseptic</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009140" MajorTopicYN="N">Musculoskeletal Diseases</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000685" MajorTopicYN="N">Serum Amyloid A Protein</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014581" MajorTopicYN="N">Urticaria</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Epidemiology</Keyword>
        <Keyword MajorTopicYN="N">Fever Syndromes</Keyword>
        <Keyword MajorTopicYN="N">Health services research</Keyword>
        <Keyword MajorTopicYN="N">Multidisciplinary team-care</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: JBK-D performed clinical studies with Novartis and received speaking honoraria from Novartis and SOBI.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2016</Year>
          <Month>8</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2016</Year>
          <Month>8</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>10</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>10</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27707729</ArticleId>
        <ArticleId IdType="doi">10.1136/annrheumdis-2016-209686</ArticleId>
        <ArticleId IdType="pii">annrheumdis-2016-209686</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
